Floatz logo

Spironolactone

Ovulation Disorder

University of VirginiaSmall moleculeEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Ovulation Disorder cohort.

Asset / SponsorPhaseRating
CLOMIPHENE CITRATE
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 4BBB
Letrozole
GABRIEL MONTEIRO PINHEIRO
Phase 4BBB
Metformin
Ain Shams Maternity Hospital
Phase 4BBB
Folate
University Magna Graecia
Phase 4BB
Hcg
Assiut University
Phase 3BB

View all 15 →

Same molecule, other indications

Spironolactone is also rated in:

AscitesDormant
BB
Indicative ·
68 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative ·
66 / 100
View asset →
diabetic kidney diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →